STAGE II BLADDER CANCER AJCC V8
Clinical trials for STAGE II BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bladder cancer drug combo trial halted before enrolling patients
Disease control TerminatedThis study was designed for people with muscle-invasive bladder cancer who cannot receive the standard chemotherapy drug cisplatin. It aimed to test whether the targeted therapy erdafitinib, alone or combined with the immunotherapy atezolizumab, could shrink tumors before surgery…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Immunotherapy boost may help bladder cancer patients avoid surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with muscle-invasive bladder cancer live longer without their cancer returning. About 475 adults with localized disease that hasn't spread are taking part. The goal is to s…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
Bladder cancer survivors: how does treatment really change your life?
Knowledge-focused OngoingThis study follows 204 people with bladder cancer to see how their treatment (surgery or radiation) affects their quality of life. Participants fill out surveys about physical function, pain, fatigue, mood, and bladder, bowel, and sexual health. The goal is to understand which tr…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 07:50 UTC